FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020682282> ?p ?o ?g. }

• W2020682282 endingPage "369" @default.
• W2020682282 startingPage "360" @default.
• W2020682282 abstract "Background. Current immunosuppression regimens are toxic to transplant recipients and, in many cases, acute rejection episodes occur because of escape of donor-reactive lymphocytes from the immunosuppression. T cells are the mediators of acute, cell-mediated graft damage and are hypothesized to use the CXCR3 chemokine axis for migration into the allograft. This study investigates the effect of CXCR3 blockade using a nonpeptide, small molecule inhibitor, AMG1237845, in murine cardiac allograft survival. Methods. C57BL/6 (H-2b) mice received vascularized cardiac allografts from A/J (H-2a) donors and were treated with the CXCR3 antagonist. Histologic and flow cytometric analyses were used to measure infiltration of leukocytes, and quantitative reverse-transcriptase polymerase chain reaction and interferon-γ ELISPOT assays were used to measure donor-specific reactivity. Results. CXCR3 antagonism modestly prolonged allograft survival compared with vehicle treatment, but at time-matched intervals posttransplant, neutrophil, CD8+, and CD4+ T cell infiltration was indistinguishable. Although proliferation of donor-reactive naïve T cells was unaffected by CXCR3 antagonism, the frequency of interferon-γ-producing cells in the recipient spleen was significantly reduced by AMG1237845 treatment. CXCR3 blockade for 30 days synergized with short-term, low-dose anti-CD154 monoclonal antibodies to prolong survival past 50 days in 75% of grafts and past 80 days in 25% of the cases. Conclusions. These results indicate that in synergy with co-stimulation blockade, CXCR3 is a viable therapeutic target to prevent acute graft rejection." @default.
• W2020682282 created "2016-06-24" @default.
• W2020682282 creator A5014810911 @default.
• W2020682282 creator A5029127396 @default.
• W2020682282 creator A5033565720 @default.
• W2020682282 creator A5053716197 @default.
• W2020682282 creator A5057315928 @default.
• W2020682282 creator A5075193114 @default.
• W2020682282 creator A5082772169 @default.
• W2020682282 creator A5085009611 @default.
• W2020682282 date "2009-02-15" @default.
• W2020682282 modified "2023-09-23" @default.
• W2020682282 title "CXCR3 Antagonism Impairs the Development of Donor-Reactive, IFN-γ-Producing Effectors and Prolongs Allograft Survival" @default.
• W2020682282 cites W1515141252 @default.
• W2020682282 cites W1522434856 @default.
• W2020682282 cites W1527965920 @default.
• W2020682282 cites W1528069886 @default.
• W2020682282 cites W1558253890 @default.
• W2020682282 cites W1795191204 @default.
• W2020682282 cites W1976161748 @default.
• W2020682282 cites W1978015875 @default.
• W2020682282 cites W1983059097 @default.
• W2020682282 cites W1984565041 @default.
• W2020682282 cites W1988019016 @default.
• W2020682282 cites W1990482372 @default.
• W2020682282 cites W2007184943 @default.
• W2020682282 cites W2026156526 @default.
• W2020682282 cites W2044996210 @default.
• W2020682282 cites W2051734282 @default.
• W2020682282 cites W2052132387 @default.
• W2020682282 cites W2058776595 @default.
• W2020682282 cites W2065589055 @default.
• W2020682282 cites W2067846827 @default.
• W2020682282 cites W2068345074 @default.
• W2020682282 cites W2069149379 @default.
• W2020682282 cites W2071917777 @default.
• W2020682282 cites W2073144597 @default.
• W2020682282 cites W2081596482 @default.
• W2020682282 cites W2084795750 @default.
• W2020682282 cites W2093624113 @default.
• W2020682282 cites W2115289037 @default.
• W2020682282 cites W2116493322 @default.
• W2020682282 cites W2119299530 @default.
• W2020682282 cites W2120056104 @default.
• W2020682282 cites W2127908593 @default.
• W2020682282 cites W2129071472 @default.
• W2020682282 cites W2129146910 @default.
• W2020682282 cites W2135034058 @default.
• W2020682282 cites W2142261360 @default.
• W2020682282 cites W2142593833 @default.
• W2020682282 cites W2145423443 @default.
• W2020682282 cites W2159861093 @default.
• W2020682282 cites W2160485534 @default.
• W2020682282 cites W4294232767 @default.
• W2020682282 doi "https://doi.org/10.1097/tp.0b013e31819574e9" @default.
• W2020682282 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2738925" @default.
• W2020682282 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19202440" @default.
• W2020682282 hasPublicationYear "2009" @default.
• W2020682282 type Work @default.
• W2020682282 sameAs 2020682282 @default.
• W2020682282 citedByCount "33" @default.
• W2020682282 countsByYear W20206822822012 @default.
• W2020682282 countsByYear W20206822822013 @default.
• W2020682282 countsByYear W20206822822014 @default.
• W2020682282 countsByYear W20206822822015 @default.
• W2020682282 countsByYear W20206822822016 @default.
• W2020682282 countsByYear W20206822822018 @default.
• W2020682282 countsByYear W20206822822021 @default.
• W2020682282 countsByYear W20206822822022 @default.
• W2020682282 countsByYear W20206822822023 @default.
• W2020682282 crossrefType "journal-article" @default.
• W2020682282 hasAuthorship W2020682282A5014810911 @default.
• W2020682282 hasAuthorship W2020682282A5029127396 @default.
• W2020682282 hasAuthorship W2020682282A5033565720 @default.
• W2020682282 hasAuthorship W2020682282A5053716197 @default.
• W2020682282 hasAuthorship W2020682282A5057315928 @default.
• W2020682282 hasAuthorship W2020682282A5075193114 @default.
• W2020682282 hasAuthorship W2020682282A5082772169 @default.
• W2020682282 hasAuthorship W2020682282A5085009611 @default.
• W2020682282 hasBestOaLocation W20206822821 @default.
• W2020682282 hasConcept C126322002 @default.
• W2020682282 hasConcept C12823836 @default.
• W2020682282 hasConcept C13373296 @default.
• W2020682282 hasConcept C167672396 @default.
• W2020682282 hasConcept C170493617 @default.
• W2020682282 hasConcept C203014093 @default.
• W2020682282 hasConcept C25532541 @default.
• W2020682282 hasConcept C2776914184 @default.
• W2020682282 hasConcept C2778468042 @default.
• W2020682282 hasConcept C2780252810 @default.
• W2020682282 hasConcept C71924100 @default.
• W2020682282 hasConcept C8891405 @default.
• W2020682282 hasConcept C98274493 @default.
• W2020682282 hasConceptScore W2020682282C126322002 @default.
• W2020682282 hasConceptScore W2020682282C12823836 @default.
• W2020682282 hasConceptScore W2020682282C13373296 @default.
• W2020682282 hasConceptScore W2020682282C167672396 @default.
• W2020682282 hasConceptScore W2020682282C170493617 @default.

• next